|
n-Hexane |
CAS 110-54-3 | ||
CH3[CH2]4CH3 |
RTECS MN9275000 | ||
Synonyms & Trade Names Hexane, Hexyl hydride, normal-Hexane |
DOT ID & Guide 1208 128 |
Exposure
|
NIOSH REL: TWA 50 ppm (180 mg/m3) | ||
OSHA PEL†: TWA 500 ppm (1800 mg/m3) | |||
IDLH 1100 ppm [10%LEL] See: 110543 | Conversion 1 ppm = 3.53 mg/m3 |
Physical Description Colorless liquid with a gasoline-like odor. |
|||
MW: 86.2 |
BP: 156°F |
FRZ: -219°F |
Sol: 0.002% |
VP: 124 mmHg |
IP: 10.18 eV |
|
Sp.Gr: 0.66 |
Fl.P: -7°F |
UEL: 7.5% |
LEL: 1.1% |
|
Class IB Flammable Liquid: Fl.P. below 73°F and BP at or above 100°F. | |||
Incompatibilities & Reactivities Strong oxidizers |
Measurement Methods NIOSH 1500, 3800; OSHA 7 See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet (flammable) Change: No recommendation |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
Important additional information about respirator selection Respirator Recommendations NIOSH Up to 500 ppm: (APF = 10) Any supplied-air respirator* Up to 1100 ppm: (APF = 25) Any supplied-air respirator operated in a continuous-flow mode* (APF = 50) Any self-contained breathing apparatus with a full facepiece (APF = 50) Any supplied-air respirator with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
Exposure Routes inhalation, ingestion, skin and/or eye contact | |
Symptoms Irritation eyes, nose; nausea, headache; peripheral neuropathy: numb extremities, muscle weakness; dermatitis; dizziness; chemical pneumonitis (aspiration liquid) | |
Target Organs
Eyes, skin, respiratory system, central nervous system, peripheral nervous system |
See also: INTRODUCTION See ICSC CARD: 0279 See MEDICAL TESTS: 0114 |